← Leaderboards
Erin Nekritz
Icahn School Of Medicine At Mount Sinai
$93,279
Attributed
$93,279
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $44.4K · FY2018–20$50K$37.5K$25K$12.5K$0
'18
'19
'20
Funding mix
By agency
NIH$93,279 · 1
By mechanism
F31$93,279 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Sarah E Millar$29,975,437
- Bachir Taouli$9,208,757
- Dani Dumitriu$3,498,993
- Thomas B Hildebrandt$10,328,843
- Saghi Ghaffari$11,733,780
Others in their field
Other Emerging Leaders on “3&Apos”
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,336,090
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Yi Su · Weill Medical Coll Of Cornell Univ$6,050,741
- Craig C Weinkauf · University Of Arizona$5,814,723
- Heidi Irma Jacobs · Massachusetts General Hospital$5,549,941
Research focus
3&AposAnimalsAlveolarBcl2 GeneBeta CateninBinding SitesBiochemicalAutomobile DrivingBreastBreast CarcinomaBreast Epithelial CellsCarcinogenesisCell DeathCellsCell TypeDiestrusBiochemical GeneticsEstrous CycleEstrusExhibitsFatty Acid Glycerol EstersFemaleFlow CytometryGenes
Grant awards (3)
Investigating the Tumor Suppressor Role of miR-424(322)/503 in Breast Cancer$5,499
F31 · FY2020 · CA · contact PI
Investigating the Tumor Suppressor Role of miR-424(322)/503 in Breast Cancer$43,416
F31 · FY2019 · CA · contact PI
Investigating the Tumor Suppressor Role of miR-424(322)/503 in Breast Cancer$44,364
F31 · FY2018 · CA · contact PI